Canada's Valeant to acquire Salix in $10.1 billion deal
February 22, 2015 at 20:05 PM EST
NEW YORK (Reuters) - Canada's Valeant Pharmaceuticals International Inc agreed to acquire gastrointestinal drugmaker Salix Pharmaceuticals Ltd in an all-cash deal valued at about $10.1 billion, the two companies said on Sunday.
